PT2841110T - Método para distribuição de antigénio - Google Patents

Método para distribuição de antigénio

Info

Publication number
PT2841110T
PT2841110T PT13726297T PT13726297T PT2841110T PT 2841110 T PT2841110 T PT 2841110T PT 13726297 T PT13726297 T PT 13726297T PT 13726297 T PT13726297 T PT 13726297T PT 2841110 T PT2841110 T PT 2841110T
Authority
PT
Portugal
Prior art keywords
antigen delivery
antigen
delivery
Prior art date
Application number
PT13726297T
Other languages
English (en)
Inventor
Ali Can Bogazici Universitesi Moleküler Biyoloji Ve Genetik Bölümü Kuzey Kampüs Kuzei Pa Sahillioglu
Nesrin Bogazici Universitesi Moleküler Biyoloji Ve Genetik Bölümü Kuzey Kampüs Kuzei Park Bin Ozoren
Original Assignee
Bogazici Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bogazici Univ filed Critical Bogazici Univ
Publication of PT2841110T publication Critical patent/PT2841110T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT13726297T 2012-04-24 2013-04-18 Método para distribuição de antigénio PT2841110T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201204773 2012-04-24

Publications (1)

Publication Number Publication Date
PT2841110T true PT2841110T (pt) 2019-05-06

Family

ID=48539332

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13726297T PT2841110T (pt) 2012-04-24 2013-04-18 Método para distribuição de antigénio

Country Status (9)

Country Link
US (1) US9725491B2 (pt)
EP (1) EP2841110B1 (pt)
JP (1) JP6026645B2 (pt)
CN (1) CN104684586B (pt)
ES (1) ES2725328T3 (pt)
HU (1) HUE043215T2 (pt)
PL (1) PL2841110T3 (pt)
PT (1) PT2841110T (pt)
WO (1) WO2013160807A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220387568A1 (en) * 2019-11-14 2022-12-08 Bogazici Universitesi Asc specks in cancer immunotherapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756196B2 (en) 1999-06-28 2004-06-29 Millennium Pharmaceuticals, Inc. Molecules of the card-related protein family and uses thereof
US6911306B1 (en) 1999-10-18 2005-06-28 Emory University TMS1 compositions and methods of use
WO2005073164A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
EP1831695B1 (en) * 2004-12-23 2009-05-06 F. Hoffmann-La Roche AG Use of cyfra 21-1 and osteopontin as markers for colorectal cancer
CA2586654C (en) * 2004-12-23 2010-10-05 F. Hoffmann-La Roche Ag Use of asc as a marker for colorectal cancer
WO2009014863A2 (en) 2007-06-29 2009-01-29 Thomas Jefferson University Asc and pyrin-asc pyroptosomes and uses thereof
US8685400B2 (en) 2007-07-30 2014-04-01 University Of Miami Modulating inflammasome activity and inflammation in the central nervous system
WO2010036918A2 (en) * 2008-09-26 2010-04-01 University Of Massachusetts Intracellular dna receptor

Also Published As

Publication number Publication date
JP6026645B2 (ja) 2016-11-16
US20150141627A1 (en) 2015-05-21
CN104684586B (zh) 2019-02-05
PL2841110T3 (pl) 2019-08-30
EP2841110A1 (en) 2015-03-04
CN104684586A (zh) 2015-06-03
WO2013160807A1 (en) 2013-10-31
US9725491B2 (en) 2017-08-08
EP2841110B1 (en) 2019-01-09
ES2725328T3 (es) 2019-09-23
JP2015515489A (ja) 2015-05-28
HUE043215T2 (hu) 2019-08-28

Similar Documents

Publication Publication Date Title
HK1199745A1 (en) Methods for obtaining a sequence
SG11201401851UA (en) Methods for drug delivery
EP2888651A4 (en) METHOD FOR GENERATING A MINI GAMES
EP2695807A4 (en) HEATING DEVICE FOR A CURRENT HAND
SG11201402161YA (en) Conveying device for leads
EP2770665A4 (en) METHOD FOR CREATING A GROUP
PT3275507T (pt) Método de administração de vacina
EP2650276A4 (en) PROCESS FOR PRODUCTION OF -FLUOROALCOOL
EP2716970A4 (en) WASTE MELTING PROCESS
HK1201800A1 (zh) 用於形成包裝的方法
GB201105436D0 (en) Method
EP2894659A4 (en) METHOD FOR MANUFACTURING A DEVICE
PL2623440T3 (pl) Sposób eksploatacji instalacji przenośnikowej
PL2925934T3 (pl) Sposób wytwarzania pala
GB201101219D0 (en) Method
SG11201503928PA (en) Method for forming a package
HK1168501A2 (en) A positioning method
GB2490312B (en) Creating a database entry
PL2841110T3 (pl) Sposób dostarczania antygenu
HK1211896A1 (en) Method for cold-cutting a lamp
EP2864078A4 (en) METHOD FOR FORMING A CONDUCT
GB2501846B (en) Case for a device
GB201106283D0 (en) Method
GB2504558B8 (en) A delivery aid
IL241069A0 (en) A method of calming a person down